Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

NCT06145893 is registered in ClinicalTrials.gov with Ganzhou Hemay Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT06145893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06145893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
Lead sponsor
Ganzhou Hemay Pharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Recruiting
Start date
November 13, 2023
Completion date
June 30, 2026
Enrollment
162 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

behçet's disease